<abstract xmlns="http://www.w3.org/1999/xhtml"><p>Ten commercially available monoclonal and polyclonal anti-A reagents were evaluated for use in the test for ABH secretor status after finding unexpected inhibition with a monoclonal anti-A (reagent Z). Two of the available monoclonal reagents were from different batches from the same clone as reagent Z. Those two reagents, as well as reagent Z, appeared to be partially neutralized by salivary substances from group A non-secretor individuals. This finding suggests that when a saliva inhibition test is done, a nonsecretor control saliva of the same ABO group as the saliva to be tested should be used.</p></abstract>

Ten commercially available monoclonal and polyclonal anti-A reagents were evaluated for use in the test for ABH secretor status after finding unexpected inhibition with a monoclonal anti-A (reagent Z). Two of the available monoclonal reagents were from different batches from the same clone as reagent Z. Those two reagents, as well as reagent Z, appeared to be partially neutralized by salivary substances from group A non-secretor individuals. This finding suggests that when a saliva inhibition test is done, a nonsecretor control saliva of the same ABO group as the saliva to be tested should be used.

Evaluation of monoclonal anti-A reagents by salivary inhibition studies

Immunohematology

{"article-title":"Evaluation of monoclonal anti-A reagents by salivary inhibition studies"}

Ten commercially available monoclonal and polyclonal anti-A reagents were evaluated for use in the test for ABH secretor status after finding unexpected...

Evaluation of monoclonal anti-A reagents by salivary inhibition studies

Published Online: Dec 29, 2020

Page range: 75 - 78

DOI: https://doi.org/10.21307/immunohematology-2019-1109

© 1988 S.M. Henry et al., published by Sciendo